Bryan Johnson spends millions on longevity research, but his team missed a critical insight from his own mitochondrial testing. Mitome's advanced analysis identifies these hidden patterns instantly—delivering the precise protocol your mitochondria actually need.
7 weeks off Metformin: new peaks in energy output. My avg cycling power improved 25.6% over my previous personal best.
Energy markers are up across the board:
2
I’ll give credit where credit is due. They did identify metformin as a complex I inhibitor, and his low complex I went up 6-fold after removing it.
3
Why was his complex II so low, why didn’t it improve at all after removing metformin, and what is he going to do about it?
4
He says “pausing Metformin unleashed my mitochondria’s full energy potential,” but how how can you consider a 50% drop in complex II to be fully unleashed?
5
Even his complex I, though 6-fold better than on metformin, is lagging behind the average by 30%, while the only thing that could be said to be fully unleashed is his complex IV.
6
He is missing some data on complex III so I can’t say the exact Mitome report he would have gotten, but I can say for sure his current protocol is skipping over some of the basics and going straight into things that could hurt his mitochondria on the next test as much as help.
7
First, the complex I and II now both need extra help and there are micronutrient commonalities between them that he hasn’t addressed.
8
Second, he’s missing key data that would tell us if he’s a candidate for methylene blue, but if his Mitome protocol included methylene blue it would never use it as a first resort because it is always better to try to fix bottlenecks than to try to work around them with unnatural substances.
9
Third, his team seems unaware that hyberbaric oxygen therapy (HBOT) and intermittent hypobaric hypoxia training (IHHT) both have profound impacts on mitochondrial function, but it isn’t that they are “good” or “bad.”
10
Instead, it’s that respiratory chain testing can reveal patterns that should tell if you if you should be using one or the other, and whether you’re getting too little or too much.
11
Hypoxia can reduce complex II, which is his weakest complex, but whether it ultimately helps or hurts it depends on the dose, intensity, duration, and frequency. But it wouldn’t surprise me if his complex II came out even worse after repeated IHHT training.
12
This doesn’t just shut down energy production, it can also lead to accumulation of specific metabolites that play a role in promoting cancer growth.
13
If Bryan had done the testing with Mitome, he would have gotten an 18-page report explaining the nutritional, lifestyle, and longevity significance of his initial results with a highly tailored protocol that would have gone way beyond removing the metformin.
14
His followup report would probably look much better.
15
More importantly, his followup report would take into account his initial results and use the changes he experienced to give greater insights into where the bottlenecks might be genetic, where they might be nutritional, and how he can take the change between tests to makes his protocol even more highly personalized.
16
Instead, his team seems to assume that metformin was promoting mitochondrial biogenesis but suppressing mitochondrial function and that this can be cycled for the benefit of both worlds, while protocols based on promoting one or the other process very generically can be used to amplify the results of cycling metformin.
17
All the data for a perfect protocol was right there—his team just couldn't read it properly. You can get better mitochondrial insights than Bryan Johnson's million-dollar team, without spending millions. Test your mitochondria at Mito.me.
Save this thread — create a free accountSave this thread